Literature DB >> 18403767

The challenge of HIV-1 subtype diversity.

Barbara S Taylor1, Magdalena E Sobieszczyk, Francine E McCutchan, Scott M Hammer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18403767      PMCID： PMC2614444          DOI： 10.1056/NEJMra0706737

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  95 in total

1.  Similar rate of disease progression among individuals infected with HIV-1 genetic subtypes A-D.

Authors:  A Alaeus; K Lidman; A Björkman; J Giesecke; J Albert
Journal:  AIDS       Date:  1999-05-28       Impact factor: 4.177

2.  K65R development among subtype C HIV-1-infected patients in tenofovir DF clinical trials.

Authors:  Michael D Miller; Nicolas Margot; Damian McColl; Andrew K Cheng
Journal:  AIDS       Date:  2007-01-11       Impact factor: 4.177

3.  Distinguishing molecular forms of HIV-1 in Asia with a high-throughput, fluorescent genotyping assay, MHAbce v.2.

Authors:  Gustavo H Kijak; Sodsai Tovanabutra; Eric Sanders-Buell; Veerachai Watanaveeradej; Mark S de Souza; Kenrad E Nelson; Vidhaya Ketsararat; Vilawan Gulgolgarn; Manu Wera-arpachai; Somchai Sriplienchan; Chirasak Khamboonrueng; Deborah L Birx; Merlin L Robb; Francine E McCutchan
Journal:  Virology       Date:  2006-09-25       Impact factor: 3.616

4.  A new classification for HIV-1.

Authors:  E A Berger; R W Doms; E M Fenyö; B T Korber; D R Littman; J P Moore; Q J Sattentau; H Schuitemaker; J Sodroski; R A Weiss
Journal:  Nature       Date:  1998-01-15       Impact factor: 49.962

5.  Subtype C Is associated with increased vaginal shedding of HIV-1.

Authors:  Grace C John-Stewart; Ruth W Nduati; Christine M Rousseau; Dorothy A Mbori-Ngacha; Barbra A Richardson; Stephanie Rainwater; Dana D Panteleeff; Julie Overbaugh
Journal:  J Infect Dis       Date:  2005-06-23       Impact factor: 5.226

6.  Reduced maximal inhibition in phenotypic susceptibility assays indicates that viral strains resistant to the CCR5 antagonist maraviroc utilize inhibitor-bound receptor for entry.

Authors:  Mike Westby; Caroline Smith-Burchnell; Julie Mori; Marilyn Lewis; Michael Mosley; Mark Stockdale; Patrick Dorr; Giuseppe Ciaramella; Manos Perros
Journal:  J Virol       Date:  2006-12-20       Impact factor: 5.103

7.  Analysis of near full-length genome sequences of HIV type 1 BF intersubtype recombinant viruses from Brazil reveals their independent origins and their lack of relationship to CRF12_BF.

Authors:  Michael M Thomson; María Sierra; Amilcar Tanuri; Silvia May; Gema Casado; Nuria Manjón; Rafael Nájera
Journal:  AIDS Res Hum Retroviruses       Date:  2004-10       Impact factor: 2.205

8.  Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand.

Authors:  Punnee Pitisuttithum; Peter Gilbert; Marc Gurwith; William Heyward; Michael Martin; Fritz van Griensven; Dale Hu; Jordan W Tappero; Kachit Choopanya
Journal:  J Infect Dis       Date:  2006-11-03       Impact factor: 5.226

9.  Human immunodeficiency viruses: SIV infection in wild gorillas.

Authors:  Fran Van Heuverswyn; Yingying Li; Cecile Neel; Elizabeth Bailes; Brandon F Keele; Weimin Liu; Severin Loul; Christelle Butel; Florian Liegeois; Yanga Bienvenue; Eitel Mpoudi Ngolle; Paul M Sharp; George M Shaw; Eric Delaporte; Beatrice H Hahn; Martine Peeters
Journal:  Nature       Date:  2006-11-09       Impact factor: 49.962

10.  The CCR5 and CXCR4 coreceptors are both used by human immunodeficiency virus type 1 primary isolates from subtype C.

Authors:  Tonie Cilliers; Jabulani Nhlapo; Mia Coetzer; Dragana Orlovic; Thomas Ketas; William C Olson; John P Moore; Alexandra Trkola; Lynn Morris
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103
View more
  202 in total

1.  Characterization of primary isolates of HIV type 1 CRF28_BF, CRF29_BF, and unique BF recombinants circulating in São Paulo, Brazil.

Authors:  Fernando Lucas Melo; Leda Fátima Jamal; Paolo Marinho de Andrade Zanotto
Journal:  AIDS Res Hum Retroviruses       Date:  2012-04-16       Impact factor: 2.205

2.  The B cell response is redundant and highly focused on V1V2 during early subtype C infection in a Zambian seroconverter.

Authors:  Rebecca M Lynch; Rong Rong; Saikat Boliar; Anurag Sethi; Bing Li; Joseph Mulenga; Susan Allen; James E Robinson; S Gnanakaran; Cynthia A Derdeyn
Journal:  J Virol       Date:  2010-10-27       Impact factor: 5.103

3.  Changes in the distribution of HIV type 1 subtypes D and A in Rakai District, Uganda between 1994 and 2002.

Authors:  Samantha A Conroy; Oliver Laeyendecker; Andrew D Redd; Aleisha Collinson-Streng; Xiangrong Kong; Fredrick Makumbi; Tom Lutalo; Nelson Sewankambo; Noah Kiwanuka; Ronald H Gray; Maria J Wawer; David Serwadda; Thomas C Quinn
Journal:  AIDS Res Hum Retroviruses       Date:  2010-10-06       Impact factor: 2.205

4.  A Pan-HIV Strategy for Complete Genome Sequencing.

Authors:  Michael G Berg; Julie Yamaguchi; Elodie Alessandri-Gradt; Robert W Tell; Jean-Christophe Plantier; Catherine A Brennan
Journal:  J Clin Microbiol       Date:  2015-12-23       Impact factor: 5.948

5.  Short Communication: Analysis of Minor Populations of Human Immunodeficiency Virus by Primer Identification and Insertion-Deletion and Carry Forward Correction Pipelines.

Authors:  Paul Hughes; Wenjie Deng; Scott C Olson; Robert W Coombs; Michael H Chung; Lisa M Frenkel
Journal:  AIDS Res Hum Retroviruses       Date:  2015-12-15       Impact factor: 2.205

6.  Refined identification of neutralization-resistant HIV-1 CRF02_AG viruses.

Authors:  Rajesh Abraham Jacob; Fatima Abrahams; Marcel Tongo; Michael Schomaker; Paul Roux; Eitel Mpoudi Ngole; Wendy A Burgers; Jeffrey R Dorfman
Journal:  J Virol       Date:  2012-05-09       Impact factor: 5.103

7.  Higher specificity of nucleic acid sequence-based amplification isothermal technology than of real-time PCR for quantification of HIV-1 RNA on dried blood spots.

Authors:  Severine Mercier-Delarue; Muriel Vray; Jean Christophe Plantier; Theodora Maillard; Zidan Adjout; Fabienne de Olivera; Nathalie Schnepf; Sarah Maylin; Francois Simon; Constance Delaugerre
Journal:  J Clin Microbiol       Date:  2013-10-16       Impact factor: 5.948

8.  Genotypic prediction of HIV-1 CRF01-AE tropism.

Authors:  Stéphanie Raymond; Pierre Delobel; Sylvie Rogez; Stéphanie Encinas; Patrick Bruel; Christophe Pasquier; Karine Sandres-Sauné; Bruno Marchou; Patrice Massip; Jacques Izopet
Journal:  J Clin Microbiol       Date:  2012-12-05       Impact factor: 5.948

Review 9.  The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic.

Authors:  Samuel Broder
Journal:  Antiviral Res       Date:  2009-12-16       Impact factor: 5.970

10.  Expanding antiretroviral options in resource-limited settings--a cost-effectiveness analysis.

Authors:  Eran Bendavid; Robin Wood; David A Katzenstein; Ahmed M Bayoumi; Douglas K Owens
Journal:  J Acquir Immune Defic Syndr       Date:  2009-09-01       Impact factor: 3.731
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.